Estiva 600mg Tablet (Efavirenz)
Prescription RequiredManufactured By
Hetero
Pack Of
30
Salt Composition
Efavirenz
Storage
Keep in cold place
Overview
Estiva 600mg Tablet (Efavirenz) is a prescription-based antiviral medication recommended by a doctor as part of a combination therapy for HIV treatment. It contains efavirenz, a salt composition that belongs to the drug class of medicines called non-nucleoside reverse transcriptase inhibitors (NNRTIs).
The medicine works by blocking the HIV-1 reverse transcriptase enzyme and stopping the virus from multiplying. The tablet is used with a combination of drugs to enhance the effectiveness of the treatment.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | estiva |
| Generic / Active Ingredient | Efavirenz |
| Strength | 600 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | Hetero |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | HIV Medicines |
| Uses | HIV |
Uses and Indications
HIV
Side Effects of Estiva 600mg Tablet
Estiva 600mg Tablet (Efavirenz) brings certain side effects in some patients, in which some are common and some are wild. If any of these symptoms persist, visit the doctor instantly:
● Headache
● Nausea
● Dizziness
● Vomiting
● Insomnia
● Sleepiness
● Abnormal dreams
● Anxiety
● Itching
● Rash
● Abdominal pain
Estiva 600mg Tablet Dosage and How To Take It
Efavirenz 600mg Tablet (Estiva) is taken orally with a glass of water. Do not crush, chew, or break the tablet, as it may affect the proper release and absorption of the medicine.
It should be taken on an empty stomach to reduce the side effects. Take the tablet at the same time every day to enhance the effectiveness of the treatment.
Safety Advice for Estiva 600mg Tablet
- ● Alcohol: Avoid or limit alcohol while taking the Estiva 600mg Tablet, as this may increase liver risk and interfere with the treatment outcomes.
- ● Driving: Estiva 600mg Tablet (Efavirenz) may cause dizziness in some patients, so try to avoid driving if you feel dizzy or experience impaired alertness.
- ● Pregnancy: Efavirenz 600mg Tablet (Estiva) must only be used by pregnant women under the supervision of a healthcare provider because there are certain risks associated with the medication that could be harmful to the unborn child.
- ● Breastfeeding: Women who are using the Estiva 600mg Tablet are not advised to breastfeed their babies, as the virus may transfer itself to the child through breastfeeding.
- ● Kidney: Use of the Estiva 600mg tablet is usually not risky for people suffering from kidney diseases, but in case there is any persistence or worsening of the problem, one must seek medical help at once.
- ● Liver: People who have liver diseases should take the Estiva 600mg Tablet (Efavirenz) cautiously because it can be harmful to their health; therefore, consulting with a doctor is very crucial at this stage.
FAQs About Estiva 600mg Tablet
1. What is Efavirenz 600mg Tablet (Estiva) used for?
The medicine is used in the treatment of HIV and AIDS by helping to control the infection and reduce the viral load in the body.
2. What is the active component of Estiva 600mg Tablet (Efavirenz)?
The active composition of the Estiva 600mg Tablet is Efavirenz, which is an antiretroviral drug used to control the growth of the Human Immunodeficiency Virus within the body.
3. Can Efavirenz 600mg Tablet (Estiva) cure HIV permanently?
Medicine does not cure HIV completely but helps control the growth and multiplication of the virus.
4. Can I take Estiva 600mg Tablet (Efavirenz) at night?
Yes, it is possible to take the Estiva 600mg tablet at night. However, it must be taken consistently at the same time to ensure consistent levels of the medication in the body.
5. What should I do if I miss a dose?
Take it as soon as you remember unless it is close to your next dose, but do not double up. It is better to consult the doctor about dose and duration to ensure safe and effective treatment.
References
● Adkins, J. C., & Noble, S. (1998). Efavirenz. Drugs, 56(6), 1055-1064.
● Vrouenraets, S. M., Wit, F. W., Tongeren, J. V., & Lange, J. M. (2007). Efavirenz: a review. Expert opinion on pharmacotherapy, 8(6), 851-871.
● Rakhmanina, N. Y., & Van den Anker, J. N. (2010). Efavirenz in the therapy of HIV infection. Expert opinion on drug metabolism & toxicology, 6(1), 95-103.
● Maggiolo, F. (2009). Efavirenz: a decade of clinical experience in the treatment of HIV. Journal of Antimicrobial Chemotherapy, 64(5), 910-928.
● Maggiolo, F. (2007). Efavirenz. Expert Opinion on Pharmacotherapy, 8(8), 1137-1145.
Marketer Details
Hetero
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
